Horizon Investments’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.95M | Buy |
13,242
+11,608
| +710% | +$6.09M | 0.11% | 149 |
|
2025
Q1 | $1.04M | Buy |
1,634
+59
| +4% | +$37.4K | 0.03% | 271 |
|
2024
Q4 | $1.12M | Buy |
1,575
+23
| +1% | +$16.4K | 0.03% | 256 |
|
2024
Q3 | $1.63M | Sell |
1,552
-99
| -6% | -$104K | 0.04% | 208 |
|
2024
Q2 | $1.74M | Buy |
1,651
+7
| +0.4% | +$7.36K | 0.05% | 184 |
|
2024
Q1 | $1.58M | Buy |
1,644
+36
| +2% | +$34.7K | 0.04% | 198 |
|
2023
Q4 | $1.41M | Buy |
1,608
+800
| +99% | +$703K | 0.04% | 190 |
|
2023
Q3 | $665K | Buy |
808
+23
| +3% | +$18.9K | 0.02% | 232 |
|
2023
Q2 | $564K | Sell |
785
-54
| -6% | -$38.8K | 0.02% | 267 |
|
2023
Q1 | $689K | Sell |
839
-577
| -41% | -$474K | 0.02% | 230 |
|
2022
Q4 | $1.02M | Sell |
1,416
-1,634
| -54% | -$1.18M | 0.03% | 216 |
|
2022
Q3 | $2.1M | Buy |
3,050
+897
| +42% | +$618K | 0.06% | 108 |
|
2022
Q2 | $1.27M | Sell |
2,153
-2,255
| -51% | -$1.33M | 0.04% | 156 |
|
2022
Q1 | $3.08M | Buy |
4,408
+793
| +22% | +$554K | 0.09% | 108 |
|
2021
Q4 | $2.28M | Buy |
3,615
+1,283
| +55% | +$810K | 0.07% | 131 |
|
2021
Q3 | $1.41M | Buy |
2,332
+620
| +36% | +$375K | 0.04% | 175 |
|
2021
Q2 | $956K | Sell |
1,712
-570
| -25% | -$318K | 0.03% | 220 |
|
2021
Q1 | $1.08M | Buy |
+2,282
| New | +$1.08M | 0.04% | 196 |
|
2020
Q4 | – | Sell |
-2,613
| Closed | -$1.46M | – | 330 |
|
2020
Q3 | $1.46M | Sell |
2,613
-2,735
| -51% | -$1.53M | 0.05% | 153 |
|
2020
Q2 | $3.34M | Buy |
5,348
+4,290
| +405% | +$2.68M | 0.08% | 112 |
|
2020
Q1 | $517K | Buy |
1,058
+114
| +12% | +$55.7K | 0.03% | 178 |
|
2019
Q4 | $354K | Buy |
+944
| New | +$354K | 0.02% | 363 |
|
2019
Q3 | – | Sell |
-705
| Closed | -$221K | – | 518 |
|
2019
Q2 | $221K | Buy |
705
+203
| +40% | +$63.6K | 0.01% | 509 |
|
2019
Q1 | $206K | Buy |
+502
| New | +$206K | 0.01% | 401 |
|